BALA CYNWYD, Pa., June 27, 2014 /PRNewswire/ -- Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Auxilium Pharmaceuticals, Inc. ("Auxilium" or the "Company") (Nasdaq: AUXL) relating to the proposed acquisition by QLT, Inc. ("QLT").
Click here to learn more about the investigation http://brodsky-smith.com/781-auxl-auxilium-pharmaceiticals-inc.html, or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the all-stock transaction, Auxilium shareholders will receive only 3.1359 QLT shares for each share of Auxilium stock they own. The investigation concerns possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Auxilium for not acting in the Company's shareholders' best interests in connection with the transaction. When consummated the transaction would result in an approximate $3.00 per share dilution for Auxilium shareholders.
If you own shares of Auxilium common stock and wish to discuss the legal ramifications of the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at email@example.com, by visiting http://brodsky-smith.com/781-auxl-auxilium-pharmaceiticals-inc.html, or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and case action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.
SOURCE Brodsky & Smith, LLC